162 related articles for article (PubMed ID: 3162703)
1. A hypothesis regarding the development of acute myeloid leukemia from preleukemic disorders. The role of protooncogenes.
Preisler HD
Cancer Genet Cytogenet; 1988 May; 32(1):133-42. PubMed ID: 3162703
[TBL] [Abstract][Full Text] [Related]
2. Preleukemia. Cytogenetic clues in some confusing disorders.
Nowell PC
Am J Pathol; 1977 Nov; 89(2):459-76. PubMed ID: 335894
[TBL] [Abstract][Full Text] [Related]
3. Human preleukemia.
Koeffler HP; Golde DW
Ann Intern Med; 1980 Aug; 93(2):347-53. PubMed ID: 6931507
[TBL] [Abstract][Full Text] [Related]
4. Cellular carcinogenesis in preleukemic conditions:drivers and defenses.
Ueda K; Ikeda K
Fukushima J Med Sci; 2024 Jan; 70(1):11-24. PubMed ID: 37952978
[TBL] [Abstract][Full Text] [Related]
5. Chronic myelogenous leukemia as a model of cancer development.
Butturini A; Gale RP
Semin Oncol; 1995 Aug; 22(4):374-9. PubMed ID: 7638634
[No Abstract] [Full Text] [Related]
6. Clonal hematopoiesis and preleukemia-Genetics, biology, and clinical implications.
Hartmann L; Metzeler KH
Genes Chromosomes Cancer; 2019 Dec; 58(12):828-838. PubMed ID: 30939217
[TBL] [Abstract][Full Text] [Related]
7. [Clinical picture and molecular disorders in myelodysplastic (MDP) syndromes].
Rupniewska ZM
Pol Arch Med Wewn; 1992 Mar; 87(3):197-208. PubMed ID: 1523148
[No Abstract] [Full Text] [Related]
8. Transforming genes in chronic myelogenous leukemia.
Liu E; Hjelle B; Bishop JM
Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1952-6. PubMed ID: 3279421
[TBL] [Abstract][Full Text] [Related]
9. Malignant progression of preleukemic disorders.
Hall T; Gurbuxani S; Crispino JD
Blood; 2024 May; 143(22):2245-2255. PubMed ID: 38498034
[TBL] [Abstract][Full Text] [Related]
10. Mapping the cellular origin and early evolution of leukemia in Down syndrome.
Wagenblast E; Araújo J; Gan OI; Cutting SK; Murison A; Krivdova G; Azkanaz M; McLeod JL; Smith SA; Gratton BA; Marhon SA; Gabra M; Medeiros JJF; Manteghi S; Chen J; Chan-Seng-Yue M; Garcia-Prat L; Salmena L; De Carvalho DD; Abelson S; Abdelhaleem M; Chong K; Roifman M; Shannon P; Wang JCY; Hitzler JK; Chitayat D; Dick JE; Lechman ER
Science; 2021 Jul; 373(6551):. PubMed ID: 34244384
[TBL] [Abstract][Full Text] [Related]
11. The preleukemic syndrome.
Biemer JJ
Ann Clin Lab Sci; 1983; 13(2):156-62. PubMed ID: 6574723
[TBL] [Abstract][Full Text] [Related]
12. Preleukemic syndrome in elderly patients--report of 11 cases.
van Dijk JM; Sonnenblick M; Kornberg A; Rosin AJ
Isr J Med Sci; 1985 Mar; 21(3):292-5. PubMed ID: 3858273
[TBL] [Abstract][Full Text] [Related]
13. [Preleukemic disorders].
Yoshida Y; Oguma S; Uchino H
Gan To Kagaku Ryoho; 1989 Feb; 16(2):149-55. PubMed ID: 2645830
[TBL] [Abstract][Full Text] [Related]
14. Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.
Preisler HD
Cancer Treat Res; 2001; 108():185-230. PubMed ID: 11702600
[No Abstract] [Full Text] [Related]
15. Abnormalities of chromosome No. 17 in myeloproliferative disorders.
Borgström GH; Vuopio P; de la Chapelle A
Cancer Genet Cytogenet; 1982 Feb; 5(2):123-35. PubMed ID: 6950807
[TBL] [Abstract][Full Text] [Related]
16. Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival in a total series of 55 patients.
Pedersen-Bjergaard J; Philip P; Pedersen NT; Hou-Jensen K; Svejgaard A; Jensen G; Nissen NI
Cancer; 1984 Aug; 54(3):452-62. PubMed ID: 6733676
[TBL] [Abstract][Full Text] [Related]
17. Implications of retroviral and oncogene activity in chronic myelogenous leukemia.
Brodsky I; Hubbell HR; Strayer DR; Gillespie DH
Cancer Genet Cytogenet; 1987 May; 26(1):15-23. PubMed ID: 2435404
[TBL] [Abstract][Full Text] [Related]
18. Point mutation of the ras protooncogenes and chromosome aberrations in acute nonlymphocytic leukemia and preleukemia related to therapy with alkylating agents.
Pedersen-Bjergaard J; Janssen WG; Lyons J; Philip P; Bartram CR
Cancer Res; 1988 Apr; 48(7):1812-7. PubMed ID: 3280121
[TBL] [Abstract][Full Text] [Related]
19. Male predominance in AML is associated with specific preleukemic mutations.
De-Morgan A; Meggendorfer M; Haferlach C; Shlush L
Leukemia; 2021 Mar; 35(3):867-870. PubMed ID: 32576964
[No Abstract] [Full Text] [Related]
20. Pure red cell aplasia as possible early manifestation of chronic myeloid leukemia.
Haas OA; Hinterberger W; Mörz R
Am J Hematol; 1988 Jan; 27(1):20-5. PubMed ID: 3128103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
